Lung transplantation: implications for the general internist

Advances in Internal Medicine

Volumn 41, Issue , 1996, Pages 497-529

  Nunley, David R ^a   Dauber, James H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERAL PRACTITIONER; HUMAN; LUNG DISEASE; LUNG TRANSPLANTATION; PATHOPHYSIOLOGY; REVIEW; TREATMENT OUTCOME;

HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; PHYSICIANS, FAMILY; TREATMENT OUTCOME;

EID: 0030330038     PISSN: 00652822     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. St. Louis International Transplant Registry: September 1994 Report. St Louis, 1994.
2. Geddes DM: Cystic Fibrosis: Future trends in care. Thorax 43:869-871, 1988.
3. Moser KM, Daily PO, Peterson K, et al: Thromboendarterectomy for chronic, major vessel thromboembolic pulmonary hypertension. Ann Intern Med 107:560-565, 1987.
4. Levine S, Gibbons W, Bryan G, et al: Single lung transplantation for primary pulmonary hypertension. Chest 98:1107-1115, 1990.
5. Keenan RJ, Surgical Director, Lung Transplantation, University of Pittsburgh: Personal communication, November 1994.
6. Toronto Lung Transplant Group: Unilateral lung transplantation for ! pulmonary fibrosis. N EngJ J Med 314:1140-1145, 1986.
7. Trulock EP, Cooper JD, Kaiser LR, et al: The Washington UniversityBarnes Hospital experience with lung transplantation. JAMA 9:583601, 1991. I
8. Snell GI, de Hoyos A, Krajden M, et al: Pseudomonas cepacia in lung transplantation recipients with cystic fibrosis. Chest 103:466-471, 1993. |
9. Flume PA, Egan TM, Paradowski LJ, et al: Infectious complications of lung transplantation: Impact of cystic fibrosis. Am J Respir Grit Care Med 149:1601-1607, 1994. !
10. Forshag MS: Transplant Pulmonologist, University of AlabamaBirmingham: Personal communication. j
11. Kerem E, Reisman J, Corey M, et al: Prediction of mortality in patients with cystic fibrosis. N EngJ J Med 103:466-471, 1992.
12. Rudd RM, Haslam PL, Turner-Warwick M: Cryptogenic fibrosis alveolitis: Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 128:1-8, 1981. j
13. Paradis IL, Manzetti JD: Medical evaluation for lung transplantation. Semin Anesth 14(2):110-122, 1995. j
14. Manzetti JD: Exercise and Quality of Life in Lung Transplant Candidates (dissertation). University of Pittsburgh, 1992.
15. Fuster V, Steele PM, Edwards WD, et al: Primary pulmonary hypertension: Natural history and the importance of thrombosis. Circulation 70:580-585, 1984. >
16. Ries AL: Position paper of the American Association of Cardiovascular and Pulmonary Rehabilitation, Scientific Basis of Pulmonary Rehabilitation. J Cardiopulm Rehabil 10:418-441, 1990.
17. Huffman LA, Wesmiller SW, Sciurba FC, et al: Nasal cannula and transtracheal oxygen delivery: A comparison of patient response following 6 months use of each technique. Am Rev Respir Dis 145:827-831, 1992. ;
18. Hodson ME, Madden BP, Steven MH, et al: Non-invasive mechanical ventilation for cystic fibrosis patients-a potential bridge to transplantation. Eur Respir J 4:524-527, 1991.
19. Guilinger RA, Dauber JH, Williams PA, et al: The role of surveillance bronchoscopy after human lung transplantation. Am J Respir Grit Care Med, in press.
20. Bryan C, Transplant Pulmonologist, University of Texas-San Antonio: Personal communication, 1995.
21. Yousem SA, Berry GJ, Brunt EM, et al: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung rejection study group. J Heart Lung Transplant 9:593-601, 1990.
22. Paradis IL, Yousem SA, Griffith BP: Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med 14:751-763, 1993.
23. Halloran PF, Broski AP, Btiuk TD, et al: The molecular immunology of acute rejection: An overview. Transplant Immunol 1:3-27, 1993.
24. Klintmalm GB: FK 506: An update. Clin Transplant 8:207-210,1994.
25. FK506 Multicenter Study Group: Randomised trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 344:423-428, 1994.
26. Shapiro R, Jordan M, Scantlebury V, et al: FK506 in clinical kidney transplantation. Transplant Proc 23:3065-3067, 1991.
27. Griffith BP, Bando K, Hardesty RL, et al: A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. Transplantation 57:848-851, 1994.
28. Yousem SA, Paradis IL, Dauber }H, et al: Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients. Transplantation 47:893-895, 1989.
29. Paradis IL, Yousem S, Griffith B: Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med 14:751-763.
30. Duncan SR, Paradis IL, Yousem SA, et al: Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis 146:1419-1425, 1992.
31. Bailey TC, Trulock EB, Ettinger NA, et al: Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants. J Infect Dis 165:548-552, 1991.
32. Snydman DR, Werner BG, Heinze-Lacey B, et al: Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal transplant recipients. N Engl J Med 317:1049-1054, 1987.
33. Gryzan S, Paradis IL, Zeevi A, et al: Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Am Rev Respir Dis 137:1268-1274, 1988.